Today

Agents

Chat

Arena

Discover

More

App

Imunon schedules Q2 results, business update conference call - IMNN News | Rallies

Imunon schedules Q2 results, business update conference call

IMNN•2026-08-04

Webcast information

Live webcast available at this link.

Conference call scheduled for Aug. 11

Imunon scheduled a conference call at 11 a.m. EDT on Aug. 11, 2026 to report Q2 2026 results.

The call is also set to provide an update on Phase 3 development of IMNN-001 in newly diagnosed advanced ovarian cancer.

Related News

QXO Inc <QXO.N>: Morgan Stanley resumes coverage with Overweight rating; price target $35

QXO•2026-08-04

Mettler-Toledo International Inc. <MTD.N>: Morgan Stanley raises target price to $1450 from $1275

MTD•2026-08-04

U.S. Research Roundup-Cloudflare, Replimune, Walmart

•

2026-08-04

Adyen partners with LillyDirect to provide payment technology services

LLY•2026-08-04

Johnson & Johnson names Tom Cavanaugh EVP, worldwide chairman of Innovative Medicine as Taubert retires

JNJ•2026-08-04